Animal study: long-term ritalin doesn't impact growth

Animal study: long-term ritalin doesn't impact growth
Chronic use of methylphenidate (Ritalin) in young monkeys has no significant effect on growth or the dopamine system, or the likelihood of becoming addicted to cocaine, according to a study published online July 18 in Neuropsychopharmacology.

(HealthDay) -- Chronic use of methylphenidate (Ritalin) in young monkeys has no significant effect on growth or the dopamine system, or the likelihood of becoming addicted to cocaine, according to a study published online July 18 in Neuropsychopharmacology.

Kathryn E. Gill, from the Wake Forest School of Medicine in Winston Salem, N.C., and colleagues treated 16 juvenile male (about 30 months old) daily with placebo or a sustained-release formulation of methylphenidate for a year, followed by a washout period of three to five months. The animals were then given the opportunity to intravenously administer cocaine over several months.

The researchers found that chronic methylphenidate treatment had no effect on weight gain or other measures of growth. Imaging studies showed no difference on the binding availability of D2/D3 receptors and dopamine transporters, although, after washout, D2/D3 receptor availability did not continue to decline at the same rate as controls. Chronic methylphenidate treatment had no effect on the propensity to acquire cocaine, overall response rates, or cocaine intake.

"In an animal model that closely mimics human development, chronic treatment with therapeutic doses of sustained-release methylphenidate did not have a significant influence on the regulation of dopamine transporters or D2/D3 receptors, or on standard measures of growth," Gill and colleagues conclude. "Furthermore, this and subsequent drug washout did not have an impact on vulnerability to ."

One author disclosed to pharmaceutical companies, including UCB Inc., which provided the methylphenidate.

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Gene therapy reduces cocaine use in rats

Apr 16, 2008

Researchers at the U.S. Department of Energy's Brookhaven National Laboratory have shown that increasing the brain level of receptors for dopamine, a pleasure-related chemical, can reduce use of cocaine by 75 percent in rats ...

Ritalin may cause changes in the brain’s reward areas

Feb 04, 2009

(PhysOrg.com) -- A common treatment for attention deficit/hyperactivity disorder, prescribed millions of times a year, may change the brain in the same ways that cocaine does, a new study in mice suggests. Research from Rockefeller ...

Attention deficit medication helps drug addicts: study

Jul 26, 2010

The active ingredient in Ritalin, a medication used to control the symptoms of attention deficit hyperactivity disorder, or ADHD, could help boost self-control in cocaine addicts, a study published Monday showed.

Receptor limits the rewarding effects of food and cocaine

Jul 12, 2011

(Medical Xpress) -- Researchers have long known that dopamine, a brain chemical that plays important roles in the control of normal movement, and in pleasure, reward and motivation, also plays a central role in substance ...

Recommended for you

User comments